Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.

Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Fact: Yes! Colorectal cancer can be fatal if diagnosed at an advanced stage. It is, therefore, considered the third leading ...

the U.S. Preventive Services Task Force issued new colon cancer screening guidance in 2021 to try to catch more cases. Now, all adults are advised to starting screening by a colonoscopy or stool ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA to aid in identifying colorectal cancer in early stages. Through polymerase chain reaction (PCR ...